Implementing the Lolli-Method and pooled RT-qPCR testing for SARS-CoV-2 surveillance in schools: a pilot project.


Journal

Infection
ISSN: 1439-0973
Titre abrégé: Infection
Pays: Germany
ID NLM: 0365307

Informations de publication

Date de publication:
Apr 2023
Historique:
received: 06 03 2022
accepted: 24 05 2022
medline: 29 3 2023
pubmed: 28 6 2022
entrez: 27 6 2022
Statut: ppublish

Résumé

School closures have been used as part of lockdown strategies to contain the spread of SARS-CoV-2, adversely affecting children's health and education. To ensure the accessibility of educational institutions without exposing society to the risk of increased transmissions, it is essential to establish SARS-CoV-2 testing strategies that are child-friendly, scalable and implementable in a daily school routine. Self-sampling using non-invasive saliva swabs combined with pooled RT-qPCR testing (Lolli-Method) has been proven to be a sensitive method for the detection of SARS-CoV-2. We conducted a pilot project in Cologne, Germany, designed to determine the feasibility of a large-scale rollout of the Lolli-Method for testing without any additional on-site medical staff in schools. Over a period of three weeks, students from 22 schools were sampled using the Lolli-Method. At the end of the project, teachers were asked to evaluate the overall acceptance of the project. We analyzed a total of 757 pooled RT-qPCRs obtained from 8,287 individual swabs and detected 7 SARS-CoV-2 infected individuals. The Lolli-Method was shown to be a feasible and accepted testing strategy whose application is only slightly disruptive to the daily school routine. Our observations suggest that the Lolli-Method in combination with pooled RT-qPCR can be implemented for SARS-CoV-2 surveillance in daily school routine, applicable on a large scale.

Identifiants

pubmed: 35759174
doi: 10.1007/s15010-022-01865-0
pii: 10.1007/s15010-022-01865-0
pmc: PMC9243733
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

459-464

Informations de copyright

© 2022. The Author(s).

Références

PLoS One. 2021 May 18;16(5):e0251589
pubmed: 34003878
Sci Rep. 2021 Sep 30;11(1):19521
pubmed: 34593887
Infection. 2021 Dec;49(6):1331-1335
pubmed: 34669162
Lancet Infect Dis. 2020 Nov;20(11):1231-1232
pubmed: 32530425
N Engl J Med. 2020 Sep 3;383(10):981-985
pubmed: 32726550
EClinicalMedicine. 2021 Aug;38:101028
pubmed: 34308321
Pediatr Res. 2022 Feb;91(3):494-501
pubmed: 32942286
Int J Infect Dis. 2021 Nov;112:130-135
pubmed: 34547492
Lancet Microbe. 2021 Jul;2(7):e311-e319
pubmed: 33846704
N Engl J Med. 2022 Jan 6;386(1):35-46
pubmed: 34752019
EClinicalMedicine. 2021 Sep;39:101082
pubmed: 34458708
Pediatr Infect Dis J. 2020 Dec;39(12):e388-e392
pubmed: 33031141
Front Pediatr. 2021 Jan 14;8:615894
pubmed: 33520898
JAMA Pediatr. 2021 Oct 1;175(10):e212022
pubmed: 34115097
Lancet. 2020 May 2;395(10234):1420-1421
pubmed: 32325027
Infection. 2021 Apr;49(2):233-239
pubmed: 33034020
Paediatr Child Health (Oxford). 2020 Dec;30(12):430-437
pubmed: 32959000
Nat Commun. 2022 Jun 25;13(1):3640
pubmed: 35752615
Infection. 2021 Aug;49(4):797-798
pubmed: 33675518

Auteurs

Alina Chloé Kretschmer (AC)

Department I of Internal Medicine, Division of Infectious Diseases, University Hospital Cologne, University of Cologne, Kerpener Str. 62, 50937, Cologne, Germany.

Lena Junker (L)

Department I of Internal Medicine, Division of Infectious Diseases, University Hospital Cologne, University of Cologne, Kerpener Str. 62, 50937, Cologne, Germany.
Federal Ministry of Education and Research (BMBF), B-FAST Project in "NaFoUniMedCovid19" (FKZ: 01KX2021), Bonn, Germany.

Felix Dewald (F)

Center for Molecular Medicine Cologne, University of Cologne, 50931, Cologne, Germany.
Institute of Virology, University Hospital Cologne, University of Cologne, Cologne, Germany.

Viktoria Linne (V)

Department I of Internal Medicine, Division of Infectious Diseases, University Hospital Cologne, University of Cologne, Kerpener Str. 62, 50937, Cologne, Germany.
German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany.
Federal Ministry of Education and Research (BMBF), B-FAST Project in "NaFoUniMedCovid19" (FKZ: 01KX2021), Bonn, Germany.

Lea Hennen (L)

Department I of Internal Medicine, Division of Infectious Diseases, University Hospital Cologne, University of Cologne, Kerpener Str. 62, 50937, Cologne, Germany.

Gibran Horemheb-Rubio (G)

Institute of Virology, University Hospital Cologne, University of Cologne, Cologne, Germany.

Rolf Kaiser (R)

Institute of Virology, University Hospital Cologne, University of Cologne, Cologne, Germany.

Gertrud Steger (G)

Institute of Virology, University Hospital Cologne, University of Cologne, Cologne, Germany.

Alexander Joachim (A)

Department of Pediatrics, University Hospital Cologne, University of Cologne, Cologne, Germany.

Jana Schönenkorb (J)

Department of Pediatrics, University Hospital Cologne, University of Cologne, Cologne, Germany.

Zülfü Cem Cosgun (ZC)

Department of Pediatrics, University Hospital Cologne, University of Cologne, Cologne, Germany.

Neslihan Mühlhans (N)

Institute of Virology, University Hospital Cologne, University of Cologne, Cologne, Germany.

Eva Heger (E)

Institute of Virology, University Hospital Cologne, University of Cologne, Cologne, Germany.

Elena Knops (E)

Institute of Virology, University Hospital Cologne, University of Cologne, Cologne, Germany.

Charlotte Leisse (C)

Department I of Internal Medicine, Division of Infectious Diseases, University Hospital Cologne, University of Cologne, Kerpener Str. 62, 50937, Cologne, Germany.

Barbora Kessel (B)

Department of Epidemiology, Helmholtz Centre for Infection Research, Brunswick, Germany.

Torben Heinsohn (T)

Department of Epidemiology, Helmholtz Centre for Infection Research, Brunswick, Germany.

Isti Rodiah (I)

Department of Epidemiology, Helmholtz Centre for Infection Research, Brunswick, Germany.

Berit Lange (B)

Department of Epidemiology, Helmholtz Centre for Infection Research, Brunswick, Germany.
German Centre for Infection Research (DZIF), TI BBD, Brunswick, Germany.

Anne Lena Ritter (AL)

School Department Cologne, Cologne, Germany.

Mira Fries (M)

Department I of Internal Medicine, Division of Infectious Diseases, University Hospital Cologne, University of Cologne, Kerpener Str. 62, 50937, Cologne, Germany.
Public Health Department Cologne, Cologne, Germany.

Annelene Kossow (A)

Public Health Department Cologne, Cologne, Germany.
Institute of Hygiene, University Hospital Muenster, Muenster, Germany.

Johannes Nießen (J)

Public Health Department Cologne, Cologne, Germany.

Jörg Dötsch (J)

Department of Pediatrics, University Hospital Cologne, University of Cologne, Cologne, Germany.

Florian Klein (F)

German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany.
Center for Molecular Medicine Cologne, University of Cologne, 50931, Cologne, Germany.
Institute of Virology, University Hospital Cologne, University of Cologne, Cologne, Germany.

Jan Rybniker (J)

Department I of Internal Medicine, Division of Infectious Diseases, University Hospital Cologne, University of Cologne, Kerpener Str. 62, 50937, Cologne, Germany.
German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany.
Center for Molecular Medicine Cologne, University of Cologne, 50931, Cologne, Germany.

Gerd Fätkenheuer (G)

Department I of Internal Medicine, Division of Infectious Diseases, University Hospital Cologne, University of Cologne, Kerpener Str. 62, 50937, Cologne, Germany.
German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany.
Federal Ministry of Education and Research (BMBF), B-FAST Project in "NaFoUniMedCovid19" (FKZ: 01KX2021), Bonn, Germany.

Isabelle Suárez (I)

Department I of Internal Medicine, Division of Infectious Diseases, University Hospital Cologne, University of Cologne, Kerpener Str. 62, 50937, Cologne, Germany. isabelle.suarez@uk-koeln.de.
German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany. isabelle.suarez@uk-koeln.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH